title: Migraine following the use of a 5-hydroxytryptamine antagonist.
authors.forename: J
authors.initials: J
authors.lastname: Siderov
authors.forename: J
authors.initials: J
authors.lastname: Zalcberg
authors.forename: B
authors.initials: B
authors.lastname: Chambers
authors.forename: G
authors.initials: G
authors.lastname: Fabinyi
mesh_terms: D004878:Ergotamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000139:chemically induced* / Q000188:drug therapy; D009837:Oligodendroglioma / Q000188:drug therapy; D017294:Ondansetron / Q000009:adverse effects*; D018170:Sumatriptan / Q000627:therapeutic use
chemical_list: D017294:Ondansetron; D018170:Sumatriptan; D004878:Ergotamine